Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00092352 | A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219) | PHASE3 | COMPLETED | 395 | — | — | Apr 29, 2003 | Dec 1, 2003 | May 9, 2017 | - | — |
| NCT00092365 | A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED) | PHASE3 | COMPLETED | 413 | — | — | Apr 1, 2003 | Nov 1, 2003 | May 9, 2017 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0966, rofecoxib | DRUG | - |
| Comparator: celecoxib, placebo | DRUG | - |
Inclusion Criteria: * Osteoarthritis of the knee which requires treatment with medication for pain relief Exclusion Criteria: * Any known allergy to the study drug